Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Adaptive Biotechnologies Corporation shareholder equity for the quarter ending December 31, 2025 were 218.8M, a 7.93% increase year-over-year.
- Adaptive Biotechnologies Corporation shareholder equity for 2025 were 218.8M, a 7.93% increase from 2024.
- Adaptive Biotechnologies Corporation shareholder equity for 2024 were 202.7M, a 34.27% decrease from 2023.
- Adaptive Biotechnologies Corporation shareholder equity for 2023 were 308.4M, a 33.56% decrease from 2022.
- Adaptive Biotechnologies Corporation shareholder equity for 2022 were 464.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adaptive Biotechnologies Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $219 |
| 2024 | $203 |
| 2023 | $308 |
| 2022 | $464 |
| 2021 | $604 |
| 2020 | $743 |
| 2019 | $571 |
| 2018 | $-258 |
| Adaptive Biotechnologies Corporation Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $219 |
| 2024-12-31 | $203 |
| 2023-12-31 | $308 |
| 2022-12-31 | $464 |
| 2021-12-31 | $604 |
| 2020-12-31 | $743 |
| 2019-12-31 | $571 |
| 2018-12-31 | $-258 |
Adaptive Biotechnologies Corporation Shareholder Equity — FAQ
Adaptive Biotechnologies Corporation (ADPT) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's shareholder equity history?
The chart and table above show Adaptive Biotechnologies Corporation's shareholder equity by year and by quarter, including the growth rate.